Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

25
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
46.46(c) 46.83(c) 47.86(c) 48.12(c) 48.55(c) Last
11 465 788 7 292 068 9 531 242 7 150 999 6 177 108 Volume
-1.88% +0.80% +2.20% +0.54% +0.89% Change
More quotes
Company
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Surperformance© rating of AbbVie Inc
Trading Rating : Investor Rating :
More about the company
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 19 155 M
EBIT 2014 6 647 M
Net income 2014 4 599 M
Debt 2014 2 833 M
Yield 2014 3,46%
Sales 2015 20 941 M
EBIT 2015 7 730 M
Net income 2015 5 738 M
Finance 2015 240 M
Yield 2015 3,70%
PER 2014 16,10
PER 2015 12,82
EV / Sales 2014 4,14x
EV / Sales 2015 3,64x
Capitalization 76 387 M
More Financials
Latest news on ABBVIE INC
1d ago ABBVIE : Assigned Patent
2d ago ABBVIE : Releases Results from Hepatitis C Study at the 2014 International Liver..
3d ago ABBVIE : Application Now Open for Students with Cystic Fibrosis for the 2014 Abb..
3d agoDJAbbott Labs Profit Falls 31%
3d ago ENANTA PHARMACEUTICALS : Posts Detailed Data from TURQUOISE-II Study in Chronic ..
4d ago ABBVIE : Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) ..
4d ago ABBVIE : Mounting AndroGel Lawsuits Prompt Petition for Federal Multidistrict Li..
04/12 ABBVIE : to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hep..
04/11 ABBVIE : Assigned Patent
04/11 ABBVIE : to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II S..
04/11 ABBVIE : ex-dividend day
04/10 ABBVIE : Patent Issued for Solid Compositions
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
AbbVie Inc : Income Statement Evolution
More Financials
EPS Revisions
AbbVie Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF